Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...
Autor principal: | Liu, C |
---|---|
Outros Autores: | Screaton, GR |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2024
|
Assuntos: |
Registos relacionados
-
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
Por: Alba Escalera, et al.
Publicado em: (2024-03-01) -
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Por: Xiao-Lin Jiang, et al.
Publicado em: (2024-07-01) -
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Por: Cyril Planchais, et al.
Publicado em: (2024-07-01) -
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Por: Jeewandara, C, et al.
Publicado em: (2021) -
Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
Por: Jay, C
Publicado em: (2023)